CMS Proposes Broad Criteria For Linking Reimbursement To Data Collection
Executive Summary
The Centers for Medicare & Medicaid Services is proposing a broad range of circumstances under which the agency could make data collection a condition for Medicare coverage of certain products and services
You may also be interested in...
CMS Splits Coverage With Evidence Development Into Two Categories
Medicare is offering added flexibility to pay for research-related expenses that arise in the clinical trials conducted for a Part B national coverage decision, under revisions to Medicare's coverage with evidence development policy, released July 12
CMS Splits Coverage With Evidence Development Into Two Categories
Medicare is offering added flexibility to pay for research-related expenses that arise in the clinical trials conducted for a Part B national coverage decision, under revisions to Medicare's coverage with evidence development policy, released July 12
CMS To Use Coverage With Evidence Development When Rx Benefit Is Likely
The Centers for Medicare & Medicaid Services will use coverage with evidence development only when an agent is highly likely to show benefit in a broader patient population than its labeled indication, CMS Senior Advisor Peter Bach said Dec. 5